Cardiac Imaging

While cardiac ultrasound is the widely used imaging modality for heart assessments, computed tomography (CT), magnetic resonance imaging (MRI) and nuclear imaging are also used and are often complimentary, each offering specific details about the heart other modalities cannot. For this reason the clinical question being asked often determines the imaging test that will be used.

ASE promoting 3D echo as a better way to treat congenital heart disease
The introduction of a 3D pediatric transesophegeal echo probe is having a major impact on how these pediatric congenital heart patients are being treated.
FDA approves new Biotronik pacing lead for LBBAP
The next-generation device includes a stylet-driven lead and a fixed helix. It was designed and developed specifically with LBBAP in mind.
Death after PCI seen in just 0.5% of patients—heart attack, cardiac arrest most common causes
The new analysis included data from more than 22,000 PCI patients treated at one of two high-volume U.S. facilities. Infection was the most common noncardiac cause of death.
Cardiologist says new legislation would delay flawed payment cuts, preserve access to care
The efficiency adjustment cuts introduced in the 2026 MPFS are based on assumptions many doctors believe to be false. The American Society of Nuclear Cardiology and other medical societies are pushing back.
Gore completes acquisition of medtech company behind next-gen heart device
Gore has officially acquired Conformal Medical, the company known for an investigational LAAO device that uses a proprietary foam implant. The transaction was first announced in January.

Enrollment in ACC NCDR increased after U.S. News and World Report said it could improve hospital rankings

Even with this bump, only about one in three eligible hospitals participate in the NCDR registries.

TEE improves 30-day outcomes for patients undergoing cardiac valve or proximal aortic surgery

Intraoperative TEE, researchers wrote, can provide value during any open cardiac valve or proximal aortic surgery.

The Corvia Atrial Shunt is designed to address elevated left atrial pressure (LAP) heart failure patients.

Implantable atrial shunt therapy trial identifies treatable HFpEF patients

The REDUCE LAP-HF II study identified heart failure patients who may benefit from receiving a new transcatheter implant manufactured by Corvia Medical.

University's research reactor increases medical isotope production in wake of supply disruption

“Our dedicated staff are committed to getting lifesaving treatments delivered to the patients who need them,” MURR's executive director said in a statement on Feb. 9.

Continued anticoagulation after primary PCI boosts survival among STEMI patients

A key takeaway from the group's analysis was that the rate of major bleeding events did not significantly change.

IVUS guidance during DES implantation boosts long-term outcomes

Researchers focused on data from two previous trials to track the impact of IVUS guidance on mortality rates and other key outcomes after three years.

Isotope update: Target date for resuming production of Mo-99 still unclear

Production of Lu-177 is expected to resume on Saturday, Feb. 12, but the Mo-99 supply shortage could continue for weeks.

The Abbott Aveir DR dual-chamber leadless pacemaker recently had its first human implant occur in the Aveir DR i2i study pivotal trial.

First implant of dual-chamber leadless pacemaker completed in Abbott’s Aveir DR i2i pivotal trial

The investigational dual-chamber pacemaker is designed to provide synchronous, beat-by-beat pacing of the right atrium and right ventricle of the heart.

Cardiac Imaging

ASE promoting 3D echo as a better way to treat congenital heart disease

FDA approves new Biotronik pacing lead for LBBAP

Death after PCI seen in just 0.5% of patients—heart attack, cardiac arrest most common causes

Cardiologist says new legislation would delay flawed payment cuts, preserve access to care

Gore completes acquisition of medtech company behind next-gen heart device